The Company is quickly advancing both its Marijuana Breath Test (MBT) with key validation work established in March, and its ...

Medical Advisory Board additions support company’s growing product offerings across women’s health and family building. NEW ...

Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...

Natural Chromium Picolinate- this ingredient helps you control hunger and food cravings. Additionally, it makes your system ...

Menopausal support (energy, mood, muscle retention): creatine is a woman’s powerful ally during the menopause face as it ...

ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.

Internationally acclaimed neurologist and epilepsy researcher Dr. Orrin Devinsky will be honored with the Lifetime Accelerator Award during the Epilepsy Therapies & Diagnostics Development Symposium ...

Columbia University, the Company’s collaboration partner for pre-clinical development, granted Silo an exclusive global license to further develop, manufacture, and commercialize SPC-15 worldwide.

Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 – SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect ...

SOUTH SAN FRANCISCO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a company pioneering targeted therapeutics that selectively activate the Wnt ...

“I also want to thank Dale for his innumerable contributions to Outset during a critical period for the company. The experience, guidance and insights he brought to the board will have a lasting ...

THE WOODLANDS, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted ...